Syndax Pharmaceuticals (SNDX) Revenue Growth (5y) (2020 - 2026)
Syndax Pharmaceuticals (SNDX) Revenue Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn |
| 10 | Syndax Pharmaceuticals | 1.85 Bn | 1.50 Bn | 53.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179.69% |
| Dec 31, 2025 | 182.79% |
| Sep 30, 2025 | 160.96% |
| Jun 30, 2025 | 151.27% |
| Mar 31, 2025 | 121.14% |
| Dec 31, 2024 | 82.44% |
| Sep 30, 2024 | 101.21% |
| Jun 30, 2024 | 55.99% |
| Dec 31, 2021 | 233.90% |
| Sep 30, 2021 | 109.72% |
| Jun 30, 2021 | 4.44% |
| Mar 31, 2021 | 4.44% |
| Dec 31, 2020 | 4.50% |
| Sep 30, 2020 | 4.44% |
| Jun 30, 2020 | 86.05% |